Plus   Neg

Accolade Prices IPO Of 10.02 Mln Shares At $22/Shr, Above The Expected Range

Accolade, Inc. announced pricing of initial public offering of 10.02 million common shares at $22.00 per share, above the estimated range. The company expects offering to close on July 7, 2020.

The company has originally filed to sell 8.75 million shares at a range of $19 to $21 share.

Accolade shares expects to begin trading on The Nasdaq Global Select Market under the ticker symbol "ACCD" on July 2, 2020.

In addition, Accolade has granted the underwriters a 30-day option to purchase up to 1.50 million additional shares of common stock at the initial public offering price less the underwriting discount and commissions.

Goldman Sachs & Co. LLC, Morgan Stanley, and BofA Securities are acting as joint book-running managers for the offering. Piper Sandler, Credit Suisse, and William Blair are acting as book-running managers. Baird and SVB Leerink are acting as co-managers.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Humana Inc. (HUM) reported second quarter adjusted earnings per share of $12.56 compared to $6.05, previous year. On average, 22 analysts polled by Thomson Reuters expected the company to report profit per share of $10.27, for the quarter. Analysts' estimates typically exclude special items. Second... H-E-B has issued an all-store recall for Blue Cheese Salmon Burgers citing the presence of an undeclared allergen, the U.S. Food and Drug Administration announced. The products contain wheat, a known allergen, which is not declared on the product label. Consumers with allergy or severe sensitivity to wheat may get serious or life-threatening allergic reaction if they consume these products. The U.S. Securities and Exchange Commission is investigating the circumstances around Eastman Kodak Co.'s (KODK) announcement of a $765 million government loan to make ingredients for Covid-19 drugs, the Wall Street Journal reported citing people familiar with the matter.
Follow RTT